Provexis (PXS)

 

Latest News

Holding(s) in Company

RNS Number: 9505D Provexis PLC 05 February 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Provexis plc 1b. Please ...

Directorate Change - Krijn Rietveld

RNS Number: 4490D Provexis PLC 31 January 2018 31 January 2018 Provexis plc Krijn Rietveld Provexis plc ('Provexis' or the 'Company') announces with great sadness that the Company's Non-executive Director Krijn Rietveld died suddenly on 28 January 2018. Dawson Buck, the Company's Chairman, said: 'We are deeply shocked and saddened by this terrible news, a...

Grant of Share Options

RNS Number: 6272A Provexis PLC 29 December 2017 29 December 2017 Provexis plc Grant of Share Options Provexis plc ('Provexis' or the 'Company'), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow heart-health functional food ingredient, announces that it has today awarded a total of 27,500,000 options ("Options") over or...

Provexis struggles to grow revenue as it reports half year results

Provexis has reported 124,259 revenue for the six months to 30 September 2017, barely above the 123,456 it generated in the ...

All News

DateHeadlineSource
05-02-18Holding(s) in CompanyRNS
31-01-18Directorate Change - Krijn RietveldRNS
02-01-18Grant of Share OptionsRNS
29-12-17Provexis struggles to grow revenue as it reports half year resultsStockMarketWire
29-12-17Half-year ReportRNS
04-12-17Patent application - Fruitflow and air pollutionRNS
10-11-17Second Price Monitoring ExtnRNS
10-11-17Price Monitoring ExtensionRNS
02-11-17Second Price Monitoring ExtnRNS
02-11-17Price Monitoring ExtensionRNS
31-10-17Second Price Monitoring ExtnRNS
31-10-17Price Monitoring ExtensionRNS
03-10-17Result of AGMRNS
26-09-17Study PublicationRNS
07-09-17Provexis sales surge by 148%StockMarketWire
07-09-17Preliminary ResultsRNS
04-08-17Holding(s) in CompanyRNS
31-07-17Results of placingRNS
28-07-17Funding UpdateRNS
03-07-17Funding UpdateRNS
09-06-17Price Monitoring ExtensionRNS
05-06-17Second Price Monitoring ExtnRNS
05-06-17Price Monitoring ExtensionRNS
19-05-17Second Price Monitoring ExtnRNS
19-05-17Price Monitoring ExtensionRNS
17-05-17Holding(s) in CompanyRNS
10-05-17Provexis expects to report on strong year of progressStockMarketWire
02-05-17Funding UpdateRNS
11-04-17Second Price Monitoring ExtnRNS
11-04-17Price Monitoring ExtensionRNS
06-04-17FTSE bogged down by ex-divs after Wall St fallsStockMarketWire
06-04-17Provexis in MoU for R&D with By-Health Co LtdStockMarketWire
06-04-17By-Health MOU and product launch for FruitflowRNS
08-02-17Second Price Monitoring ExtnRNS
08-02-17Price Monitoring ExtensionRNS
30-12-16Provexis narrows H1 pretax lossStockMarketWire
30-12-16Half-year ReportRNS
21-12-16Second Price Monitoring ExtnRNS
21-12-16Price Monitoring ExtensionRNS
20-12-16FTSE supported by banks after MBNA acquisition StockMarketWire

RSS feeds

  • Editorial news feed for LSE:PXS Editorial
  • Regulatory news feed for LSE:PXS Regulatory